HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetanus shot may improve glioblastoma treatment.

Abstract
Preconditioning the immune system with a tetanus/diphtheria toxoid significantly improved the effectiveness of dendritic cell immunotherapy and extended overall survival in a small, randomized study of patients with glioblastoma.
Authors
JournalCancer discovery (Cancer Discov) Vol. 5 Issue 6 Pg. 571 (Jun 2015) ISSN: 2159-8290 [Electronic] United States
PMID25877510 (Publication Type: Journal Article, Comment)
Copyright©2015 American Association for Cancer Research.
Chemical References
  • Cancer Vaccines
  • Chemokine CCL3
  • Tetanus Toxoid
Topics
  • Animals
  • Cancer Vaccines (immunology)
  • Chemokine CCL3 (immunology)
  • Dendritic Cells (drug effects)
  • Female
  • Glioblastoma (immunology, therapy)
  • Humans
  • Tetanus Toxoid (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: